FDA Adverse Event Injury Summary report: N

FMP HIP

MDR report key: 3900066 · Received June 27, 2014

Report

Report Number
1644408-2014-00394
Event Type
Injury
Date Received
June 27, 2014
Date of Event
June 24, 2014
Report Date
June 24, 2014
Manufacturer
ENCORE MEDICAL, L.P.
Product Code
LPH
PMA / PMN Number
K974093
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE REASON FOR THIS SURGERY WAS IDENTIFIED AS POLY WEAR OF THE ACETABULAR LINER AFTER APPROXIMATELY 10 YEARS OF PATIENT USE; PRODUCT IN-VIVO DURATION CANNOT BE DEFINITIVELY DETERMINED SINCE A CONFIRMED DATE FOR IMPLANTING IS UNKNOWN BUT IS ESTIMATED TO APPROXIMATELY 10 YEARS. THERE IS NO INFORMATION SUPPLIED ABOUT ANY PATIENT INJURIES, ACTIVITIES, ACCIDENTS, OR MEDICAL CONTRAINDICATIONS THAT MAY HAVE CONTRIBUTED TO THE NEED FOR THIS REVISION. THERE WAS NO DELAY IN SURGERY AND ANOTHER SUITABLE DEVICE WAS AVAILABLE FOR USE. THE REVISION SURGERY WAS COMPLETED AS INTENDED. THE DEVICE WAS DISPOSED OF AT THE HOSPITAL AND NOT MADE AVAILABLE TO DJO SURGICAL FOR EXAMINATION. A REVIEW OF THE PRODUCT DEVICE HISTORY RECORDS WAS NOT CONDUCTED SINCE THE LOT NUMBER WAS NOT REPORTED FOR THIS EVENT AND COULD NOT BE ESTABLISHED OR DETERMINED. EXTENDED SEARCHES OF THE PATIENT DATABASE PRODUCED NO ADDITIONAL INFORMATION CONCERNING THE ORIGINAL SURGERY OR FURTHER IDENTIFIED THE SPECIFIC IDENTITY OF THE PRODUCT. THE ROOT CAUSE FOR THE REVISION SURGERY IS IDENTIFIED AS POLY WEAR OF THE ACETABULAR LINER. WITHOUT ADDITIONAL INFORMATION THE CAUSE OF THE PRODUCT WEAR CANNOT BE DETERMINED WITH CONFIDENCE OTHER THAN NORMAL USE. THERE ARE NO INDICATIONS OF A PRODUCT OR PROCESS ISSUE AFFECTING IMPLANT SAFETY OR EFFECTIVENESS.

Description of Event or Problem · 1

REVISION SURGERY - DUE TO POLY WEAR; THE SURGEON REPLACED THE IMPLANT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
378006 FMP HIP LINER - 10 DEGREE HOODED, MP8 LPH ENCORE MEDICAL, L.P.

Patients

Seq Age Sex Outcome Treatment
1 77 YR Required Intervention